Foff Erin Pennock has filed 5 insider transactions across 1 company since October 2025.
Most recent transaction: a grant/award of 13360 shares of MapLight Therapeutics, Inc. ($MPLT) on February 05, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 5, 2026 | MapLight Therapeutics, Inc. | $MPLT | Foff Erin Pennock | Chief Medical Officer | A | Voting Common Stock | 13360 | $0.00 | 403,835.0000 | 45,373,033 | 3.42% | 0.03% |
| Feb. 5, 2026 | MapLight Therapeutics, Inc. | $MPLT | Foff Erin Pennock | Chief Medical Officer | A | Employee Stock Option (right to buy) | 54240 | $0.00 | 54,240.0000 | 45,373,033 | 9999.99% | 0.12% |
| Jan. 27, 2026 | MapLight Therapeutics, Inc. | $MPLT | Foff Erin Pennock | Chief Medical Officer | F | Voting Common Stock | 44616 | $17.98 | 390,475.0000 | 45,373,033 | 10.25% | 0.10% |
| Oct. 27, 2025 | MapLight Therapeutics, Inc. | $MPLT | Foff Erin Pennock | Chief Medical Officer | A | Voting Common Stock | 48275 | $0.00 | 48,275.0000 | 0 | 9999.99% | 0.00% |
| Oct. 27, 2025 | MapLight Therapeutics, Inc. | $MPLT | Foff Erin Pennock | Chief Medical Officer | A | Employee Stock Option (right to buy) | 196035 | $0.00 | 196,035.0000 | 0 | 9999.99% | 0.00% |